abstract |
Novel ligand compounds having the structural formula (I): n n n n n n n n n n in which:n Ar is a radical selected from among the radicals of formulae (a)-(c) below: nn n n n n n n n n n are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions. |